Projects per year
Search results
-
Active
A Phase 1/2 Open-Label, Ascending Dose, Multicenter Study to Evaluate the Safety and Preliminary Efficacy of AVB-101 administered by Bilateral Intrathalamic Infusion in Subjects with Frontotemporal Dementia With Progranulin Mutations (FTD-GRN)
Masdeu, J. C. (PI), Pascual, B. (Key Personnel) & Toledo, J. B. (Key Personnel)
2/26/25 → …
Project: Clinical Trial
-
Cerebral tau deposition and comorbid cerebrovascular disease across the Alzheimer's disease continuum in Mexican Americans
Toledo, J. B. (PI)
8/15/24 → 8/31/29
Project: Federal Funding Agencies
-
Biomarker in Aging-Related Disorders (BARD)
Toledo, J. B. (PI), Faridar, A. (Key Personnel), Masdeu, J. C. (Key Personnel) & Pascual, B. (Key Personnel)
4/23/24 → …
Project: Clinical Trial
-
Lewy Body Dementia Association Research Centers of Excellence Award
Toledo, J. B. (PI)
1/1/24 → 12/31/25
Project: Non Profit
-
Houston Alzheimer Disease Study
Masdeu, J. C. (PI), Faridar, A. (Key Personnel), Karmonik, C. (Key Personnel), Nakawah, M. O. (Key Personnel), Pascual, B. (Key Personnel), Roman, G. C. (Key Personnel), Toledo, J. B. (Key Personnel) & Wong, S. T. (Key Personnel)
5/17/21 → …
Project: Clinical Trial
-
A Study of Donanemab (LY3002813) in Participants With Early Alzheimer's Disease (TRAILBLAZER-ALZ 2)
Toledo, J. B. (PI) & Masdeu, J. C. (Key Personnel)
3/12/21 → …
Project: Clinical Trial
-
Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of AL001 in FTD (AL001-3) (INFRONT-3)
Masdeu, J. C. (PI), Faridar, A. (Key Personnel), Pascual, B. (Key Personnel) & Toledo, J. B. (Key Personnel)
10/20/20 → …
Project: Clinical Trial
-
Ocrelizumab for Psychosis by Autoimmunity (OPA)
Masdeu, J. C. (PI), Faridar, A. (Key Personnel), Madan, A. (Key Personnel), Nakawah, M. O. (Key Personnel), Pascual, B. (Key Personnel), Toledo, J. B. (Key Personnel) & Weinstein, B. (Key Personnel)
2/20/20 → …
Project: Clinical Trial
-
AHEAD 3-45 Study: A Placebo-Controlled, Double-Blind, Parallel-Treatment Arm, 216 Week Study to Evaluate Efficacy and Safety of Treatment With BAN2401 in Subjects With Preclinical Alzheimer¿s Disease and Elevated Amyloid (A45 Trial)
Masdeu, J. C. (PI), Toledo, J. B. (PI), Faridar, A. (CoI) & Nakawah, M. O. (CoI)
9/30/19 → 5/31/25
Project: Federal Funding Agencies
-
NMDA Receptor in Psychosis: Specific Auto-Antibodies
Masdeu, J. C. (PI), Faridar, A. (Key Personnel), Nakawah, M. O. (Key Personnel), Pascual, B. (Key Personnel) & Toledo, J. B. (Key Personnel)
11/14/16 → …
Project: Clinical Trial
-
Neuroimaging in AD
Masdeu, J. C. (PI), Faridar, A. (Key Personnel), Karmonik, C. (Key Personnel), Nakawah, M. O. (Key Personnel), Pascual, B. (Key Personnel), Roman, G. C. (Key Personnel) & Toledo, J. B. (Key Personnel)
9/15/16 → …
Project: Clinical Trial
-
Finished
-
AHEAD 3-45 Study: A Study to Evaluate Efficacy and Safety of Treatment With BAN2401 in Subjects With Preclinical Alzheimer¿s Disease and Elevated Amyloid (A45 Trial) and in Subjects With Early Preclinical Alzheimer¿s Disease and Inter Amyloid (A3 Trial)
Masdeu, J. C. (PI), Toledo, J. B. (PI), Faridar, A. (CoI) & Nakawah, M. O. (CoI)
6/1/19 → 4/30/24
Project: Federal Funding Agencies